Drug-Eluting Balloons

Most Popular Stories of 2012

To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click on when visiting the website. Below are the top 25 stories from 2012, and the top 10 stories read in 2012 that were written in pre...

Companies Developing Drug-Eluting Balloons

Several paclitaxel drug-eluting balloons (DEBs) are currently available on the European market, and several others are in development. There are currently no DEBs available in the United States.

VNT Poised for Breakthrough Interventional Applications...
Vascular Nanotransfer Technologies (VNT) says it has developed the industry’s most versatile drug-coated-balloon (DCB) platform designed to deliver a wide...
Top stories of 2012 in cardiology
Most Popular Stories of 2012
To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click on when visiting the website. Below are...
Covidien Announces Definitive Agreement to Acquire CV...
December 26, 2012 — Covidien announced a definitive agreement to acquire CV Ingenuity. The companies expect to complete the acquisition in the first...
Primus Drug-Eluting Balloon Balloon Catheters Peripheral Artery Disease devices
Drug-Eluting Balloons Bounce Into Global Market
November 1, 2012 — It looks as though drug-eluting balloons (DEBs), already widely used in Europe, are set to burst into the global market as heart conditions...

Articles

Top stories of 2012 in cardiology
Most Popular Stories of 2012
To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click on when visiting the website. Below are...
Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study
April 17, 2012 –– Expanding its commitment to developing innovative treatments for cardiovascular disease and the evidence to support their adoption, Medtronic...
Companies Developing Drug-Eluting Balloons
Several paclitaxel drug-eluting balloons (DEBs) are currently available on the European market, and several others are in development. There are currently no...
Devices Offer New PAD Treatment Options
In recent years, many medical device companies saw the underserved lower extremity as an opportunity to enter the market for peripheral artery disease (PAD)...

Video Center

view all Videos »

The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
11 weeks 5 hours ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
15 weeks 2 days ago
Innovation Exasperation
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
19 weeks 11 hours ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...

Comparison Charts

Sorry there is no data available